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Abstract: The GABAA receptor is an oligopentameric chloride channel that is 
activated via conformation changes induced upon the binding of the 
endogenous ligand, GABA, to the extracellular inter-subunit interfaces. While 
dozens of amino acid residues at the /β interface have been implicated in 
ligand binding, the structural elements that mediate ligand binding and 
receptor activation are not yet fully described. Here, double-mutant cycle 
analysis was employed to test for possible interactions between several 
arginines (1R67, 1R120, 1R132, and β2R207) and two aromatic residues 
(β2Y97 and β2F200) that are present in the ligand-binding pocket and are 
known to influence GABA affinity. Our results show that neither 1R67 nor 
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1R120 is functionally coupled to either of the aromatics, while a moderate 
coupling exists between 1R132 and both aromatic residues. Significant 
functional coupling between β2R207 and both β2Y97 and β2F200 was found. 
Furthermore, we identified an even stronger coupling between the two 
aromatics, β2Y97 and β2F200, and for the first time provided direct evidence 
for the involvement of β2Y97 and β2F200 in GABA binding. As these residues 
are tightly linked, and mutation of either has similar, severe effects on GABA 
binding and receptor kinetics, we believe they form a single functional unit 
that may directly coordinate GABA. 
Keywords: GABAA receptor, GABA binding, functional coupling 
Introduction 
The GABAA receptors are members of the ligand-gated ion 
channel (LGIC) superfamily, which also includes nicotinic acetylcholine, 
serotonin (5-HT3), and glycine receptors. Each of the LGICs is 
activated by a unique endogenous ligand, binding of which leads to a 
specific activation pattern (i.e. opening and closing) of the intrinsic ion 
channel. It is the nature of these receptor-ligand interactions that 
defines the role each LGIC plays in information processing in the 
central nervous system. Consequently, it is of paramount importance 
to determine the molecular details of this process. 
A profusion of studies have contributed to our understanding of 
the interaction between the GABAA receptors and their endogenous 
ligand, γ-aminobutyric acid (GABA). From these, it is clear that the 
GABA binding site is located at the interface of the  and β subunits 
(Cromer et al. 2002; Kash et al. 2004), and a multitude of amino acid 
residues that are both located at this interface and mediate GABA 
affinity have been identified (Lummis 2009). In addition, the general 
architecture of the binding site has been determined through 
homology modeling (Cromer et al. 2002). However, details of the 
molecular interactions that underlie the ligand-receptor interaction 
remain elusive. 
A particularly intriguing possibility is that the positively charged 
amino group of GABA may interact with an aromatic residue in the 
GABA-binding pocket via a cation- bond. Padgett et al. (2007) tested 
for this using unnatural amino acid substitution and found that a 
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tyrosine in the binding pocket, β2Y97, participates in a cation- bond 
that is immediately involved in GABA affinity. As a result they, very 
reasonably, concluded that β2Y97 directly interacts with the amino 
group of GABA. However, the possibility remains that β2Y97’s cation 
partner is, instead, one of the multiple arginine residues located in the 
GABA binding pocket. These include 1R67, 1R120, 1R132, and 
β2R207, all of which have been shown to mediate GABA affinity 
(Westh-Hansen et al. 1999; Holden and Czajkowski 2002; Wagner et 
al. 2004; Laha and Wagner 2011). 
Here, we utilized double-mutant cycle analysis to test for 
potential interactions between β2Y97 and each of 1R67, 1R120, 
1R132, and β2R207, by quantifying functional coupling in the context 
of changes in free energy that result from mutating amino acid 
residues in singles and in pairs. We also tested for functional coupling 
between each arginine and β2F200, another aromatic residue located 
in the GABA-binding pocket that has been shown to influence GABA 
affinity (Wagner and Czajkowski 2001). Our results identify functional 
coupling between two of the arginines (1R132, β2R207) and both 
β2Y97 and β2F200. Furthermore, we demonstrated an even tighter 
coupling between β2Y97 and β2F200. We concluded that β2Y97 and 
β2F200 form a single functional unit that is critical for GABA binding. 
The Y97/F200 pair could interact with the ammonium moiety of GABA 
via a cation- bond and its position may be fine-tuned via secondary 
interactions with β2R207 and/or 1R132. Interestingly, by determining 
the binding rates of GABA, we provided direct evidence for the 
involvement of β2Y97 and β2F200 in GABA binding, for the first time. 
Last but not least, we found that neither 1R67 nor 1R120 is 
functionally coupled to the aromatics, ruling out any interactions 
thought to exist between them. 
Materials and methods 
cDNA constructs and mutagenesis 
Human 1, β2, and γ2S subunits were inserted into the pcDNA 
3.1 vector. Desired subunit combinations were transiently expressed in 
HEK-293 cells by transfection of vectors containing the corresponding 
genes. An engineered β2 variant (β2-GKER) was originally used in order 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
 
Journal of Neurochemistry, Vol. 119, No. 2 (October 2011): pg. 283-293. DOI. This article is © Wiley and permission has 
been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to 
be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
4 
 
to rescue expression with 1β2-GKER receptors containing point 
mutations either on 1 or β2. β2-GKER has four amino acids of β2 replaced 
with the aligned residues found on the β3 subunit, D171G, N173K, 
T179E, and K180R (Taylor et al. 1999; Bollan et al. 2003). This 
subunit has been shown to assemble more efficiently (Bollan et al. 
2003) and we have found no differences in kinetics, apparent GABA 
affinity (EC50-GABA), or amplitude comparing to β2-containing receptors. 
However, β2-GKER was later found insufficient to rescue expression for 
several mutations; in such instances, co-expression with the γ2S 
subunit allowed rescue. For consistency, 1β2-GKERγ2S receptors were 
used as the control in the present study. Mutant 1 and β2 subunits 
were created using the QuikChange II site-directed mutagenesis kit 
(Stratagene, La Jolla, CA), and double stranded sequencing of the 
entire coding region was conducted in order to verify fidelity. 
Cell culture, transfection, and labeling 
Human embryonic kidney (HEK-293) cells were cultured in 
Minimum Essential Medium Eagle with Earle’s salts (Mediatech, 
Manassas, VA), supplemented with 10% newborn calf serum (Thermo 
Scientific, Waltham, MA) and Penicillin-Streptomycin-Glutamine 
(Mediatech) in a 37° C incubator under a 5% CO2 atmosphere. Cells 
were plated onto 35 mm dishes coated with poly-L-lysine and were 
transfected 24 hours later using Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA) with the following amounts of cDNAs: 500 ng of eGFP, 1 
μg of 1 (wild-type or mutant), 1 μg of β2-GKER (wild-type or mutant), 
and 3 μg of γ2S. eGFP was used as a marker to identify transfected 
cells. Patch clamp recordings were carried out 48–72 hours post-
transfection. 
Electrophysiology 
All recordings for this study were collected from outside-out 
patches excised from HEK-293 cells. GABA-evoked chloride currents 
were recorded from patches voltage clamped at −60 mV, at room 
temperature. Recordings were made using borosilicate glass pipettes 
filled with (in mM): 140 KCl, 10 EGTA, 2 MgATP, 20 phosphocreatine 
and 10 HEPES, pH 7.4. Rapid solution exchange was accomplished by 
using a multibarreled flowpipe array (Vitrodynamics, Rockaway, NJ) 
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mounted on a piezoelectric bimorph (Vernitron, Bedford, OH). A 
computer-controlled constant current source drove the bimorph to 
move solution interfaces over the patch with 10–90% exchange times 
of ~200 μs, as measured by the liquid junction current at the open 
pipette tip after each experiment. GABAA receptor agonists and 
antagonists were dissolved in the perfusion solution, which contains (in 
mM): 145 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 4 mM Glucose, 
and pH 7.4. For extracellular solutions that contained more than 30 
mM GABA, the concentration of NaCl was reduced to 95 mM, and a 
combination of sucrose and GABA was added to compensate for the 
reduced osmolarity. The pipette solution was adjusted in conjunction, 
reducing the KCl concentration to 90 mM, and 50 mM K-gluconate was 
added to maintain a constant Cl− driving force. GABA and SR-95531 
were obtained from Sigma-Aldrich Chemicals, St Louis, MO. Currents 
were low-pass filtered at 2–5 kHz with a four-pole Bessel filter and 
digitized at a rate no less than twice the filter frequency. Data were 
collected at 20 kHz using an Axopatch 200B amplifier (Axon 
Instruments, Foster City, CA) and an ITC-1600 digitizer (InstruTech, 
Port Washington, NY), controlled by Axograph X software (Axograph 
Scientific, Sydney, AUS). Macroscopic current ensembles were 
collected with 15-second intervals between consecutive solution 
applications. 
Antagonist unbinding experiments 
Outside-out patches were pre-equilibrated in SR-95531 for 750 
ms, and then rapidly switched to a solution containing saturating 
GABA. The evoked current was shaped by the convolution of the time 
course of antagonist unbinding and the waveform of the control 
current (evoked with no pre-equilibration in antagonist). Home-written 
Matlab (Mathworks, Natick, MA) routines were used for the 
deconvolution of the time course of antagonist unbinding from this 
evoked current (Jones et al. 2001). The time course of antagonist 
unbinding was fit with an exponential function, yielding koff-SR and the 
percentage of receptors occupied by antagonist at equilibrium. The 
experiment was repeated several times, pre-equilibrating in different 
test concentrations of SR-95531. KD-SR was determined by plotting the 
antagonist occupancy versus concentration. The binding rate of SR-
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95531 (kon-SR) was calculated from the known values of koff-SR and KD-
SR. 
Measuring the microscopic binding rate of GABA 
The microscopic binding rate of GABA (kon-GABA) was measured 
using “race” experiments (Jones et al. 1998). In a race experiment, 
agonist (having an unknown binding rate) is co-applied with an 
antagonist, which has a previously determined binding rate (kon-ant, see 
“Antagonist Unbinding Experiments” above). The amplitude of the 
current evoked by co-application of agonist and antagonist is 
compared to the amplitude of current evoked by agonist alone, and 
this ratio (Iag-ant/Iag-only) is called Irace. Irace depends only on the relative 
concentrations and binding rates of agonist and antagonist. The only 
unknown is the agonist binding rate, kon-agonist, which can be solved for 
using the following equation:  
 
Double-mutant cycle analysis 
Mutant cycle analysis was performed on EC50 values and binding 
rates. ΔΔG′o was calculated as RT ln (kmutant/kwild-type), where R is the 
ideal gas constant (1.987 calories/mole), T is the absolute 
temperature (296 K), and k is either EC50-GABA or kon-GABA. EC50 values 
have been previously utilized to support side chain interactions and 
establish coupling coefficients (Kash et al. 2003; Price et al. 2007; 
Venkatachalan and Czajkowski 2008). If two mutations have 
independent effects, ΔΔG′o(1,2) = ΔΔG′o (1) + ΔΔG′o (2). For our 
evaluation, the further a coupling energy [ΔΔG′ocoupling = ΔΔG′o (1,2) − 
(ΔΔG′o (1) + ΔΔG′o (2))] deviates from 0 kcal/mol the less functionally 
independent the two residues are from one another. 
Statistical methods 
Graphpad Prism 4 (GraphPad Software, Inc., San Diego, CA) 
was employed for fitting concentration-response curves and 
performing statistical significance test. For concentration-response 
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curves, relative mean ± SEM was plotted against the GABA 
concentration. The resulting plot was fitted with a form of the Hill 
equation, Y = Min + (Max − Min)/(1 + 10^((LogEC50 − X) * 
HillSlope)), where X is the log value of the GABA concentration. 
Significant differences between control and mutant parameters, where 
appropriate, were tested using ANOVA with a Dunnett’s post-test, at a 
significant level of p < 0.05. 
Results 
The present study sought to employ double-mutant cycle 
analysis to test for potential interactions between arginines (1R67, 
1R120, 1R132, and β2R207) and aromatics (β2Y97 and β2F200) 
located in the GABAA receptor ligand-binding pocket. The targeted 
amino acid residues were mutated singly and in pairs. In order to 
achieve consistent expression, all of the mutations were expressed in a 
background of 1β2-GKERγ2s, which also served as our control construct 
(Bollan et al. 2003; Laha and Wagner 2011). For readability, the 
mutant constructs will be referred to as R67A, R120A, R132A, R207A, 
Y97A, F200I, R120A-Y97A, R120A-F200I, R132A-Y97A, R132A-F200I, 
R207A-Y97A, R207A-F200I, Y97A-F200I, and Y97A-F200I-R207A to 
indicate the corresponding single, double, or triple mutant receptor. 
Each mutation tested increases EC50-GABA 
Each of the arginines and aromatics of interest was mutated to 
alanine and transiently expressed in HEK-293 cells, in order to record 
GABA-evoked currents from outside-out patches. EC50-GABA was 
determined by fitting concentration-response plots with a form of the 
Hill equation. Overall, EC50-GABA measured at peak response for every 
single and double mutant tested displayed a significant rightward shift 
ranging from 288 μM (4-fold, R132A) to 22.65 mM (310-fold, R207A-
F200I) compared to control (EC50-GABA 1β2-GKERγ2S = 73 μM) (Figure 1). 
These shifts in EC50-GABA values are entirely consistent with previously 
published results, which suggest each of these residues mediate GABA 
affinity. 
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Figure 1 EC50-GABA double-mutant cycle analysis identified pairs of amino acid 
residues that are functionally coupled. EC50-GABA was obtained through concentration-
response experiments in which the peak currents from a series of sub-saturating 
concentrations of GABA were compared to the peak currents at saturating GABA. The 
concentration-response plot was fit with a form of the Hill equation to obtain an EC50 
value. A–D) Concentration response curves for wild-type, Y97A, and F200I; unique to 
each plot are the curves for specific arginine single mutant and the corresponding two 
double mutants containing that particular arginine. E) The double mutant Y97A-F200I 
concentration-response plot is identical to that of the single mutant F200I; both are 
right-shifted compared to wild-type. The concentration-response analysis yielded the 
following EC50-GABA values (in mM): wild-type, 0.073; R67A, 4.80; R120A, 0.85; 
R132A, 0.29; R207A, 0.70; Y97A, 1.06; F200I, 6.50; R120A-Y97A, 17.89; R132A-
Y97A, 2.31; R132A-F200I, 12.93; R207A-Y97A, 3.26; R207A-F200I, 22.65; Y97A-
F200I, 5.04. The EC50-GABA values could not be accurately determined for R67A-Y97A, 
R67A-F200I, and R120A-F200I double mutations. F) Double-mutant cycle analysis 
schematic and a summary of the coupling energies determined. 
Because these EC50-GABA values are used to drive double-mutant 
cycle analysis in this study, it is crucial that accurate values of this 
parameter are determined for each construct analyzed. This can be 
particularly challenging for double-mutant constructs having EC50-GABA 
values >10 mM, which require GABA concentrations of 100 mM or 
greater to achieve saturation for the GABA-evoked current response. 
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We found that we could get consistent results using GABA 
concentrations of up to 160 mM, but issues of osmotic imbalance 
across the patch precluded us from employing higher concentrations. 
Because of this, we could not accurately quantify EC50-GABA for some of 
the more severely shifted constructs (R67A/F200I, R67A/Y97A, and 
R120A/F200I). We confirmed that the GABA-evoked response was 
effectively saturated for each of the remaining constructs by analyzing 
the rise time of the initial activation phase of the current. The 
activation rate has a higher saturation point than the peak current 
amplitude (Li and Pearce 2000), and we verified that the activation 
rate for each mutant receptor reached a plateau (Figure 2). 
 
Figure 2 Activation phase of GABA-evoked current saturates at high GABA 
concentration. A) Overlayed raw wild-type currents activated by varying 
concentrations of GABA, from multiple patches. B) Overlayed raw F200I-R207A 
currents activated by varying concentrations of GABA, from multiple patches. In both, 
black horizontal bar indicates GABA application. The activation (rising) phase of each 
current was fit by a single-exponent equation, yielding an activation time constant 
(τactivation). 1/τactivation was used to calculate the activation rate. C) Plot of normalized 
activation rate of each receptor construct with respect to GABA concentration. Each 
plot was fit with a form of the Hill equation. 
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In later experiments that depend on the competitive antagonist 
SR-95531, it was found that the β2F200A mutation could not be used 
because it causes a debilitating reduction in SR-95531 affinity. 
Therefore, a milder mutation, β2F200I, was tested. β2F200I was found 
to adequately support SR-95531 binding and had less severe effects 
on EC50-GABA than β2F200A, making it very useful for the double-mutant 
cycle analysis studies that followed. 
Double-mutant cycle analysis of EC50-GABA reveals little 
coupling between the arginines from the 1 subunit and 
β2Y97 or β2F200 
This study aimed to assess the relationships between residues 
using the method of double-mutant cycle analysis. Double-mutant 
cycle analysis quantifies the extent of functional coupling between two 
residues by comparing the changes in free energy (ΔΔG) resulting 
from single mutations and the corresponding double mutation, to 
measure the likelihood of two residues interacting (Horovitz 1996). 
One parameter that has been commonly used for double-mutant cycle 
analysis, in the study of proteins such as LGICs, is the apparent 
affinity for ligand, or the EC50 value (Kash et al. 2003; Price et al. 
2007; Venkatachalan and Czajkowski 2008). 
As a single mutation, R67A caused the largest shift in EC50-GABA, 
and when combined with either Y97A or F200I even more severe shifts 
were observed (Figure 1A). Curve fits to the concentration-response 
data for either double mutant were not possible because the responses 
never approached saturation. In addition, for either double mutant, 
propofol-evoked currents (1 mM) displayed peak amplitudes greater 
than twice those evoked by 160 mM GABA (the highest concentration 
tested, data not shown), suggesting that EC50-GABA for either of these 
constructs is greater than 160 mM. Because we were not able to 
accurately quantify EC50-GABA for these constructs we could not subject 
them to double-mutant cycle analysis. However, the fact that the 
double mutations are so debilitating is suggestive that no functional 
coupling exists between 1R67 and either β2Y97 or β2F200, and it is 
unlikely that 1R67 shares an interaction with either aromatic residue. 
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As was seen for R67A, when R120A was co-expressed with F200I, the 
effect on EC50-GABA was too severe to be quantified and the two 
residues are not likely to be functionally coupled. On the other hand, 
R120A-Y97A receptors displayed a measurable EC50-GABA (17.9 mM). 
This value, along with the EC50-GABA values for R120A (850 μM) and 
Y97A (1.06 mM), were used to drive double-mutant cycle analysis, 
which resulted in a coupling energy of 0.23 kcal/mol (Figure 1B, F). It 
should be noted that, double-mutant cycle analysis works on the 
premise that if two residues are perfectly independent, we would 
expect the coupling energy to be 0 kcal/mol. As such, any value that 
deviates from zero may indicate coupling. The further a coupling 
energy deviates from 0 kcal/mol the less functionally independent the 
two residues are from one another. Direct interactions typically have 
coupling energies that exceed |0.5 kcal/mol| (Kash et al. 2003; Price 
et al. 2007; Venkatachalan and Czajkowski 2008). Therefore, 1R120 
does not appear to be significantly coupled to β2Y97 and it is not likely 
to participate in an interaction with either aromatic residue. 
The double-mutant cycle analyses of R132A, with respect to 
Y97A and F200I, yielded modest coupling energies of −0.35 kcal/mol 
and −0.41 kcal/mol for R132-Y97 and R132-F200 pairs, respectively 
(Figure 1C, F). Although these coupling energies are not particularly 
strong, the values cannot be entirely disregarded and may indicate 
possible interactions. Interestingly, 1R132 appears to be coupled to 
β2Y97 and β2F200 with the same magnitude. 
Double-mutant cycle analysis of EC50-GABA reveals a 
ternary functional interaction between β2R207, β2Y97, 
and β2F200 
When R207A was co-expressed with Y97A or F200I, double 
mutant cycle analysis revealed significant coupling energies (−0.67 
kcal/mol and −0.56 kcal/mol for the R207A-Y97A and R207A-F200I 
pairs respectively, Figure 1D, F). These coupling energies indicate that 
β2R207 is tightly coupled to the aromatics, and it is possible that 
β2R207 interacts with one or the other (i.e. via a cation- bond). 
We find it interesting that, as was also seen for 1R132, β2R207 
is coupled to both β2Y97 and β2F200 to a similar degree. This similarity 
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in coupling would be predicted if β2Y97 and β2F200 are tightly linked 
structurally, effectively acting as a single functional unit. If this is the 
case, then double-mutant cycle analysis of the two aromatics should 
give a strong coupling energy. Indeed, the Y97A-F200I double 
mutation revealed a highly significant coupling energy (−1.72 
kcal/mol) between β2Y97 and β2F200 (Figure 1E, F). Taken together, 
the strong coupling energies of β2R207/β2Y97, β2R207/β2F200, and 
β2Y97/β2F200 suggest that these three residues act together as single 
functional ternary complex to mediate GABA binding. 
Triple mutant cycle analyses revealed unequal 
partnerships among ternary complex members: 
β2R207, β2Y97, and β2F200 
To further dissect the relationship between members of the 
ternary complex, we performed triple mutant cycle analyses. In other 
words, we carried out double mutant cycle analysis measuring 
coupling of two residues on the background of a third mutant. The only 
new data needed to perform this analysis was the EC50-GABA for the 
triple mutant, Y97A-F200I-R207A. This construct displayed robust 
GABA-evoked current and caused a 305-fold decrease in GABA affinity, 
(EC50-GABA = 22.2 mM). When double-mutant cycle analysis was applied 
to β2Y97 and β2F200 in a R207A background, strong coupling was still 
observed (ΔΔGCoupling = −0.92 kcal/mol, Figure 3C). However, strong 
coupling of β2R207 with β2Y97 disappeared when tested on the F200I 
background (ΔΔGCoupling = 0.14 kcal/mol, Figure 3A), as did coupling of 
β2R207 with β2F200 on the Y97A background (ΔΔGCoupling = 
0.21kcal/mol, Figure 3B). These coupling energies indicate that the 
presence of both β2Y97 and β2F200 is necessary for β2R207’s 
participation in the ternary complex. On the other hand, the presence 
of β2R207 is not absolutely necessary for the functional interaction 
between β2Y97 and β2F200, despite a slight reduction in coupling 
energy. 
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Figure 3Functional coupling between β2R207 and one of the two aromatic residues 
exists only in the presence of the other aromatic residue. Top row shows concentration 
response curves comparing the effects on GABA affinity caused by double mutants and 
triple mutant in the background of a single mutant control. Bottom row shows the 
double-mutant cycle analyses and the resulting coupling energies. A) β2R207 is not 
functionally coupled to β2Y97 when β2F200 is mutated. B) β2R207 is not functionally 
coupled to β2F200 when β2Y97 is mutated. C) β2Y97 and β2F200 remains coupled 
when β2R207 is mutated. 
Coupling between β2R207, β2F200, and β2Y97 mediates 
GABA binding 
While EC50-GABA is a useful parameter for driving double-mutant 
cycle analysis, it represents a complex interaction between several 
microscopic processes (i.e. ligand binding/unbinding, channel 
opening/closing, desensitization/resensitization) (Colquhoun 1998; 
Gleitsman et al. 2008). Therefore, we thought it would be informative 
to directly measure the GABA binding rate (kon-GABA) for each construct 
and repeat double-mutant cycle analysis using this microscopic 
parameter. Such direct evidence for a residue’s participation in GABA 
binding was previously demonstrated for β2R207 (Wagner et al. 2004) 
but has not been done for β2Y97 and β2F200. 
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kon-GABA was measured as previously described by Jones et al. 
(2001). Briefly, this process first involves determining the binding rate 
for a competitive antagonist, in this case SR-95531 (Supplemental 
Figure 1). Once the binding rate for SR-95531 (kon-SR) is obtained, the 
binding rate of GABA can be determined by performing an experiment 
in which GABA and SR-95531 are co-applied, known as a race 
experiment. The resulting co-application current is compared to the 
current evoked by the application of GABA alone. The extent to which 
the peak current is reduced by the presence of the antagonist depends 
on the relative binding rates of the two compounds and the relative 
concentrations available. kon-SR is determined by the antagonist 
unbinding experiment, and then kon-GABA is calculated as kon-GABA = [SR-
95531] kon-SR/([GABA](1/Irace −1)) (Jones et al. 1998). Irace is the ratio 
of the peak response of co-application to the peak response of GABA 
alone. 
The effects of each single mutant and double mutant receptor 
on the kinetics of SR-95531 and kon-GABA are summarized in Table 1. 
Alanine substitution at β2R207 had no effect on KD-SR. On the other 
hand, mutation of β2F200 and β2Y97 strongly affected SR-95531 
affinity causing 55 and 20-fold increases in KD-SR, respectively. This 
result supports the idea that β2Y97 and β2F200 are a tightly coupled 
functional group. Also, both β2Y97 and β2F200, as well as β2R207, 
influence the kon-GABA. Results from application of the kon-GABA values to 
double-mutant cycle analysis generally agreed with those seen from 
EC50-GABA (Figure 4). β2Y97 and β2F200 remain coupled (ΔΔGCoupling = 
1.09 kcal/mol), as do β2R207 and β2F200 (ΔΔGCoupling = 0.56 kcal/mol). 
The coupling energy for β2R207 and β2Y97 dropped slightly to 0.40 
kcal/mol, but is high enough that a potential interaction that mediates 
GABA binding remains possible. These results show that β2Y97, 
β2F200, and β2R207 likely form a ternary complex that mediates GABA 
binding. 
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Figure 4 Functional coupling between β2Y97, β2F200, and β2R207 at the 
microkinetic level (kon-GABA). A–G) Sample raw traces recorded from race experiments. 
The solution exchange protocol was designed to alternate between control (only GABA, 
500ms, gray) and test (GABA and SR-95531 simultaneously, 500ms, black) every 15 
seconds. The known concentrations of GABA and SR and the ratio of GABA+SR: GABA 
only (IRace) were used to calculate kon-GABA (see methods). H) Summary of the coupling 




Cation- bonding has been demonstrated to be a universal 
structural motif in proteins. In a cation- bond the  orbital electrons 
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from aromatic amino acid side chain (Trp, Tyr, Phe) interact with a 
cation. The cation may be provided by a basic residue (Arg, Lys, His) 
on the same subunit as the aromatic residue (Gallivan and Dougherty 
1999), a basic residue from a different subunit (Crowley and Golovin 
2005), or a positively charged exogenous ligand (Zacharias and 
Dougherty 2002). Cation- bonds have been demonstrated to be key 
players in ligand binding for all members of the cys-loop LGIC family 
(Zhong et al. 1998; Beene et al. 2002; Lummis et al. 2005; Padgett et 
al. 2007; Pless et al. 2008). 
At least five aromatic residues from the GABAA receptor (1F65, 
β2Y97, β2Y157, β2F200, and β2Y205) have been implicated in ligand 
binding (Sigel et al. 1992; Boileau et al. 1999; Boileau et al. 2002; 
Amin and Weiss 1993; Wagner and Czajkowski 2001). Padgett et al. 
(2007) demonstrated that one of these, β2Y97, participates in a cation-
 bond that mediates ligand binding and that 1F65, β2Y157, and 
β2Y205 do not participate in functionally important cation- 
interactions. The remaining aromatic, β2F200, remains untested for 
cation- interaction. 
In this study we employed double-mutant cycle analysis to test 
for possible interactions among candidate residues that have cation- 
ability at the GABA-binding pocket. Functional coupling between either 
β2Y97 or β2F200 and each of the arginines present in the GABA-binding 
pocket (1R67, 1R120, 1R132, and β2R207) was measured. Our 
results identify 1R132 and β2207 as potential cation- partners for 
each of the aromatics, and rule out 1R67 and 1R120. In addition, a 
strong and consistent coupling was identified between the two 
aromatics themselves, suggesting that β2Y97 and β2F200 directly 
interact. 
β2Y97 and β2F200 as a tight aromatic pair 
The clearest result from this study is that β2Y97 and β2F200 
work together as a single functional unit. When double-mutant cycle 
analysis, using EC50-GABA, was employed to test for coupling between 
β2R207 and either β2Y97 or β2F200, the results were comparable 
(ΔΔGCoupling: R207/Y97 = −0.67 kcal/mol, R207/F200 = −0.56 
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kcal/mol). Similarly, 1R132 was found to be equally coupled to each 
aromatic residue (ΔΔGCoupling: R132/Y97 = −0.35 kcal/mol, R132/F200 
= −0.41 kcal/mol). These results strongly suggest that β2Y97 and 
β2F200 work in concert. This hypothesis is supported by the fact that 
the two residues are strongly coupled to each other when the 
mutational effects on EC50-GABA (ΔΔGCoupling Y97/F200 = −1.72 
kcal/mol), kon-GABA (ΔΔGCoupling Y97/F200 = 1.09 kcal/mol) and koff-SR 
(ΔΔGCoupling = −1.59 kcal/mol) are used to drive the double-mutant 
cycle analysis. Furthermore, mutation of either residue had 
qualitatively similar effects on every parameter we measured: EC50-
GABA, koff-SR, kon-SR, and kon-GABA. 
Another line of evidence supporting a tight interaction between 
β2Y97 and β2F200 comes from the fact that coupling between β2R207 
and each aromatic was abolished when tested in a background where 
the other aromatic residue had been mutated. In other words, 
whatever interaction β2R207 might share with β2Y97 disappears when 
β2F200 is mutated, and whatever interaction β2R207 shares with 
β2F200 disappears when β2Y97 is mutated. Conversely, the coupling 
energy between β2Y97 and β2F200 is only modestly reduced by 
mutation of β2R207. 
Taken altogether, these results suggest that β2Y97 and β2F200 
form a single functional unit that then interacts with β2R207 and 
possibly 1R132. It is likely that these interactions between β2R207, 
1R132, and the Y97/F200 complex occur via a cation- bond(s) with 
either aromatic, but it is also possible that the interaction of β2Y97 and 
β2F200 positions other elements (i.e. neighboring side chains or 
backbone carbonyls) for interactions with either of the arginines. 
The role of arginines from the 1 subunit 
Of the arginines from the 1 subunit that were tested, we found 
that 1R132 can potentially interact with either β2Y97 or β2F200 but 
that neither 1R67 nor 1R120 is likely to participate in any 
interactions with either of the two aromatics. When expressed as a 
single mutation, 1R132A has relatively moderate effects on EC50-GABA 
(4-fold increase), suggesting that it might act to help position the 
more critical Y97/F200 pair rather than directly coordinating the GABA 
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molecule. The lack of an interaction between 1R120 and the aromatics 
is not particularly surprising. According to the homology model, 
1R120 is relatively distant from the aromatics and it has been 
proposed to participate in a state-dependent inter-subunit salt bridge 
with β2D163 (Cromer et al. 2002; Laha and Wagner 2011). The fact 
that 1R67 does not interact with the aromatics examined here but is 
located nearby and, on its own, severely affects GABA affinity suggest 
that it plays a critical role in GABA binding that is independent of the 
Y97/F200 pair. 
A model of the GABA binding pocket 
The current best structural model of the GABAA receptor ligand-
binding pocket is the homology model that has been developed based 
on the crystal structure of the molluscan acetylcholine binding protein 
(AChBP) (Brejc et al. 2001; Cromer et al. 2002; O’Mara et al. 2005). 
In this homology model the distance between the aromatic rings of 
β2Y97 and β2F200 ranges from 6–9 angstroms when the side chains 
are rotated through their stable conformations. This distance is too 
great to support direct aromatic-aromatic interaction and may appear 
to be evidence against the tight Y97/F200 interaction proposed here. 
However, β2F200 is located at the apex of Loop C, a region that aligns 
very poorly with the AChBP (Cromer et al. 2002) and whose actual 
structure is likely to differ significantly from the AChBP structure (Ernst 
et al. 2003). In addition, Loop C appears to be quite flexible (Wagner 
and Czajkowski 2001; Bourne et al. 2010). Therefore, we believe the 
results presented here have provided a new constraint on the 
homology model and that future versions of the model should attempt 
to translate the alpha carbon of β2F200 a few angstroms so that it can 
interact with β2Y97. Figure 5 illustrates a possible orientation of GABA 
at the binding pocket. 
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Figure 5 Interpretation of our results at the GABA binding pocket: a model of the 
GABA binding pocket based on the homology structure proposed by Cromer et al. 
(2002). A) Side-view of β/ interface showing the side chains of all the residues 
mutated in this study. GABA has been manually placed in its proposed orientation 
between R67 and F200/Y97. B) Zoomed view of panel A with backbone removed. The 
alpha carbon of each residue has not been moved from its original position in the 
homology model (Cromer et al. 2002). Several of the side chains have been rotated to 
alternate stable positions (using the mutate function in Swiss PDB viewer). The side 
chain of F200 has been slightly rotated using the torsion function in Swiss PDB viewer. 
The proposed stacking interaction between β2Y97 and β2F200 
could leave the alternate faces available for cation- bonding with the 
amino group of GABA. Because β2F200 has significantly stronger 
effects on GABA affinity, we propose that it serves as a docking point 
for the GABA amino group. This leaves β2Y97 available for cation- 
interaction with β2R207 or 1R132. The homology model ideally 
positions 1R132 for this interaction. Therefore, in our model we 
choose to depict it thusly, and show β2R207 contributing via 
interaction(s) with the backbone carbonyl of β2Y97, which it perfectly 
reaches according to the homology model. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
 
Journal of Neurochemistry, Vol. 119, No. 2 (October 2011): pg. 283-293. DOI. This article is © Wiley and permission has 
been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to 
be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
20 
 
So far, this model leaves the question of where the carboxyl 
group of GABA docks. The guanidinium group of an arginine could 
serve as the docking site for the GABA carboxyl group. Specifically, 
1R67 has previously been proposed as a potential docking site for this 
moiety (Padgett et al. 2007). This hypothesis is supported by the fact 
that, of the four arginines tested here, mutation of 1R67 to alanine 
has the largest effects on both the GABA binding rate and the GABA 
unbinding rate (unpublished data). Furthermore, 1R67A and β2F200I, 
as single mutations, have the most severe effects on GABA affinity and 
these effects appear fully additive in the R67A-F200I double mutant. 
This result supports a model in which 1R67 and β2F200 serve as 
critical and independent sites that coordinate the carboxyl end and the 
amino end of GABA respectively. 
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Supplemental Figure 1.  Antagonist unbinding experiments. A) 
Sample raw traces recorded from antagonist unbinding experiments. 
Solution exchange protocol was designed to go in the sequence of 
500 ms in saturating GABA solution, 15 seconds in wash, then 500 
ms in a test concentration of SR-95531 followed immediately by 500 
ms in saturating GABA solution, back to wash for 15 seconds, and 
the cycle repeats. The resulting raw data was analyzed to determine 
the microscopic kinetics, KD, koff, and kon, for SR-95531. The 
sample raw traces show current resulted from control GABA (blue) 
and pre-equilibration (red). B) Deconvolution of GABA-evoked 
currents after SR-95531pre-equilibration from control currents (no 
pre-equilibration) reveals the time course of SR-95531 unbinding. 
Deconvolutions were fit to the equation  
A(t) = [P∞ - (P∞-P0)exp(-t/τu)]
N
, 
where A(t) is the fraction of available receptors (antagonist not 
bound at any site), P0 and P∞ are the probabilities that a single 
binding site is available initially at t = 0 and at steady state as t→∞, 
τu is the time constant of antagonist unbinding from each site (koff-
SR = 1/τu), and N is the number of binding sites (Jones et al. 
2001).  C) Concentration-response curves, for the equilibrium 
antagonist occupancy in the absence of GABA A(t = 0), were fit to 
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